Pharmaceutical application of LC-MS. 1 — Characterization of a famotidine degradates in a package screening study by LC-APCI MS

This publication has 12 references indexed in Scilit:

• Thermal Degradation of Famotidine in Aqueous Solution Stability Indicating Assay
  Analytical Letters, 1992
• Determination of L-654,066, a new 5α-reductase inhibitor in plasma by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry
  Journal of Mass Spectrometry, 1992
• Quantitative analysis by high-performance liquid chromatography atmospheric pressure chemical ionization mass spectrometry: The determination of the renin inhibitor CP-80,794 in human serum
  Journal of the American Society for Mass Spectrometry, 1991
• Validation of a method for the assay of related compounds in famotidine raw materials and formulations
  Journal of Pharmaceutical and Biomedical Analysis, 1989
• Biochemical applications of liquid chromatography-mass spectrometry
  Journal of Chromatography B: Biomedical Sciences and Applications, 1989
• Quantitation of Famotidine in Pharmaceutical Dosage Forms Using High-Performance Liquid Chromatography
  Drug Development and Industrial Pharmacy, 1989
• Reversed-phase determination of famotidine, potential degradates, and preservatives in pharmaceutical formulations by high-performance liquid chromatography using silica as a stationary phase
  Journal of Chromatography A, 1986
• Analytical method for the quantification of famotidine, an H2-receptor blocker, in plasma and urine
  Journal of Chromatography B: Biomedical Sciences and Applications, 1985
• Liquid chromatography mass spectrometry in the pharmaceutical industry: Objectives and needs
  Journal of Chromatography A, 1982
• Adduct ion formation in chemical ionization mass spectrometry of nonvolatile organic compounds
  Analytical Chemistry, 1981